Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · IEX Real-Time Price · USD
1.960
-0.040 (-2.00%)
At close: Jul 2, 2024, 4:00 PM
1.900
-0.060 (-3.06%)
After-hours: Jul 2, 2024, 6:43 PM EDT
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of $135.24 million as of July 2, 2024. Its market cap has increased by 160.57% in one year.
Market Cap
135.24M
Enterprise Value
106.83M
1-Year Change
160.57%
Ranking
Category
Stock Price
$1.96
Market Cap Chart
Since August 10, 2021, Cardiol Therapeutics's market cap has increased from $102.60M to $135.24M, an increase of 31.81%. That is a compound annual growth rate of 10.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 125.60M | 130.04% |
| Dec 29, 2023 | 54.60M | 68.52% |
| Dec 30, 2022 | 32.40M | -60.20% |
| Dec 31, 2021 | 81.40M | -20.66% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acumen Pharmaceuticals | 140.29M |
| TriSalus Life Sciences | 140.14M |
| Caribou Biosciences | 139.54M |
| Repare Therapeutics | 139.22M |
| Context Therapeutics | 138.00M |
| Invivyd | 136.62M |
| Quantum-Si incorporated | 134.64M |
| ProQR Therapeutics | 134.51M |